(Date:7/23/2008)...swire-USNewswire/ -- The American Heart,Associatio... Lewis,Achievement Award, the association,s highes...ard was established in 2000, to recognize and hono...edical journalists who have documented,the conside...ease and,stroke. This career achievement award was...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The Alameda County,P...ly 24-26 at the Oakland,Marriott to address the so...in individuals from low-income and communities of ...s and counties will attend. Place Matters,is a nat... and Economic,Studies, Health Policy Institute and...
(Date:7/23/2008)...e Dangerous for Morbidly Obese Women? ,As the ...are consulting plastic surgeons for breast reducti...ad been thought to have higher complication rates....e as safe to perform large-volume breast reduction...Study title: Breast Reduction: Safe in the Morbidl...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The New Jersey,Hospi...t Safety has,received a planning grant for $199,50...o develop a proposal for improving the quality of,...termine over the next six months whether New,Jerse... Quality initiative,which is focused on lifting t...
Breaking Medicine News(10 mins):Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2(Date:7/23/2008)... SEATTLE, July 23 /- D...ed that it expects the Independent Data,Monitoring...terim analysis,of overall survival relating to the...ate AdenoCarcinoma Treatment, also known as D9902B...OVENGE is the Company,s investigational,active cel...
(Date:7/22/2008)... Latest awards under Therapeutics Development...ollaborations to 23; next deadline January 20,200...s part of its mission to,speed delivery of transfo...ase, The Michael J. Fox Foundation for Parkinson,s...g to six industry research teams. The awards,were ...
(Date:7/22/2008)... CEO Geoffrey Allan Will Stress the Importance...On Biologics Approval Pathway, RICHMOND, Va., Jul...,CM: INSM) a developer of follow-on biologics and ...Allan, Ph.D., CEO of Insmed, will present at a,Con...discuss the,significant need for establishing an a...
(Date:7/22/2008)... SOPHIA ANTIPOLIS, France, July 22 /PRNewswir...oday announced it has successfully completed the,e... controlled hypertension,in two clinical pharmacol...viously announced timelines. These trials are desi...xcinod, in comparison to ibuprofen and,naproxen, u...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Harlequin frog rediscovered in remote region of Colombia 2472 1Harlequin frog rediscovered in remote region of Colombia 2472 2SEIU 3A Thousands of Ohio Nurses and Other Healthcare Employees Denied a Voice at Work After Vicious Union Busting Campaign by the California Nurses A 14072 1SEIU 3A Thousands of Ohio Nurses and Other Healthcare Employees Denied a Voice at Work After Vicious Union Busting Campaign by the California Nurses A 14072 2Red light cameras increase crashes researchers find 14068 1Red light cameras increase crashes researchers find 14068 2Red light cameras increase crashes researchers find 14068 3New twist on lifes power source 2468 1New twist on lifes power source 2468 2New twist on lifes power source 2468 3.../PRNewswire-FirstCall/ --,Alpharma Inc. , a leadin...its Pharmaceuticals Division, this week presented ... investigational,abuse-deterrent, extended-release...he American Pain Society in Washington, D.C.,The d...is,extended-release morphine sulfate plus sequeste...
...lank" href=,"http://www.omxgroup.com/">www.omxgrou...Y) , , STOCKHOLM, Sweden, May 3, 2007 – Du...he Sweden-Seattle Diabetes Conference,this past we...,Investigator in Diamyd’s previously reporte...esented potentially scientifically,ground-breaking...
Other Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 2Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 3Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 5...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: